Parenteral Long-Acting Antiseizure Medications Are Used More Often to Treat Seizure Clusters Than Convulsive Status Epilepticus in the Pediatric Emergency Department
Restricted accessResearch articleFirst published online June, 2022
Parenteral Long-Acting Antiseizure Medications Are Used More Often to Treat Seizure Clusters Than Convulsive Status Epilepticus in the Pediatric Emergency Department
Objective:Recent trials provide high-quality evidence for second-line treatment of convulsive status epilepticus (CSE) in children. However, the most effective medications for other seizure emergencies are poorly understood without established treatment algorithms. We investigated children presenting to the emergency department with repetitive or prolonged convulsions who required intravenous long-acting antiseizure medications, to determine the relative importance and treatment responsiveness of status epilepticus and seizure clusters. Methods: Retrospective observational study in the emergency department, Royal Children's Hospital, Melbourne, Australia (annual census 90 000) using hospital electronic medical records data of patients presenting with seizures in 2018. For patients receiving parenteral long-acting antiseizure medications, seizures were categorized as convulsive status epilepticus, nonconvulsive status epilepticus, and seizure clusters. Results: 1468 patients (2% of all visits) presented with seizures to the emergency department in 2018. Long-acting antiseizure medications were administered to 97 (7%) children for the emergency management of seizures. The majority presented with seizure clusters (n = 69; 71%). Only 11 (11%) were in convulsive status epilepticus and 17 (18%) in nonconvulsive status epilepticus. In convulsive status epilepticus, nonconvulsive status epilepticus, and seizure clusters, phenytoin was used in 27%, 53%, and 58% and levetiracetam in 73%, 47%, and 32%, respectively. Conclusions:Convulsive status epilepticus represents a small portion of patients requiring parenteral long-acting antiseizure medications. Seizure clusters accounted for >6 times the number of convulsive status epilepticus, yet evidence and treatment algorithms are lacking.
HuffJSMorrisDLKothariRUGibbsMA. Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med. 2001;8(6):622‐628. doi:10.1111/j.1553-2712.2001.tb00175.x
2.
PallinDJGoldsteinJNMoussallyJSPelletierAJGreenARCamargoCAJr. Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int J Emerg Med. 2008;1(2):97‐105. doi:10.1007/s12245-008-0024-4
3.
ShinnarSBergATMosheSLShinnarR. How long do new-onset seizures in children last?Ann Neurol. 2001;49(5):659‐664.
4.
Raspall-ChaureMChinRFMNevilleBGScottRC. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5(9):769‐779. doi:10.1016/S1474-4422(06)70546-4
5.
Advanced Life Support Group. Advanced Paediatric Life Support: A Practical Approach to Emergencies. 6th ed. Wiley-Blackwell; 2016.
6.
GlauserTShinnarSGlossD, et al.Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48‐61. doi:10.5698/1535-7597-16.1.48
7.
McTagueAMartlandTAppletonR. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2018;1:Cd001905. doi:10.1002/14651858.CD001905.pub3
8.
PrasadMKrishnanPRSequeiraRAl-RoomiK. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev. 2014;2014(9):CD003723. doi:10.1002/14651858.cd003723.pub3
9.
DalzielSRBorlandMLFurykJ, et al.Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135‐2145. doi:10.1016/S0140-6736(19)30722-6
10.
KapurJElmJChamberlainJM, et al.Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103‐2113. doi:10.1056/NEJMoa1905795
11.
LyttleMDRainfordNEAGambleC, et al.Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125‐2134. doi:10.1016/S0140-6736(19)30724-X
BerginPSBrockingtonAJayabalJ, et al.Status epilepticus in Auckland, New Zealand: incidence, etiology, and outcomes. Epilepsia. 2019;60(8):1552‐1564. doi:10.1111/epi.16277
15.
SinghRKStephensSBerlMM, et al.Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology. 2010;74(8):636‐642. doi:10.1212/WNL.0b013e3181d0cca2
16.
ChenJXieLHuYLanXJiangL. Nonconvulsive status epilepticus after cessation of convulsive status epilepticus in pediatric intensive care unit patients. Epilepsy Behav. 2018;82:68‐73. doi:10.1016/j.yebeh.2018.02.008
17.
ShnekerBFFountainNB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology. 2003;61(8):1066‐1073. doi:10.1212/01.wnl.0000082653.40257.0b
18.
TaySKHirschLJLearyLJetteNWittmanJAkmanCI. Nonconvulsive status epilepticus in children: clinical and EEG characteristics. Epilepsia. 2006;47(9):1504‐1509. doi:10.1111/j.1528-1167.2006.00623.x
19.
PenovichPEBuelowJSteinbergKSirvenJWhelessJ. Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives. Neurologist. 2017;22(6):207‐214. doi:10.1097/nrl.0000000000000140
GiladRIzkovitzNDabbyR, et al.Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin. Acta Neurol Scand. 2008;118(5):296‐300. doi:10.1111/j.1600-0404.2008.01097.x
23.
IncecikFHorozOOHergunerOM, et al.Intravenous levetiracetam in critically ill children. Ann Indian Acad Neurol. 2016;19(1):79‐82. doi:10.4103/0972-2327.167702
24.
KhongkhatithumCThampratankulLWiwattanadittakulNVisudtibhanA. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures. Eur J Paediatr Neurol. 2015;19(4):429‐434. doi:10.1016/j.ejpn.2015.02.010
25.
LeeYJYumMSKimEHKoTS. Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures. Korean J Pediatr. 2016;59(1):35. doi:10.3345/kjp.2016.59.1.35
26.
McTagueAKneenRKumarRSpintySAppletonR. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children’s hospital. Seizure. 2012;21(7):529‐534. doi:10.1016/j.seizure.2012.05.010
27.
NgampoopunMSuwanpakdeePJaisupaNNabangchangC. Effectiveness and adverse effect of intravenous lacosamide in nonconvulsive status epilepticus and acute repetitive seizures in children. Neurol Res Int. 2018;2018:8432859. doi:10.1155/2018/8432859
28.
FisherRSCrossJHD’SouzaC, et al.Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017;58(4):531‐542. doi:10.1111/epi.13671
29.
TrinkaECockHHesdorfferD, et al.A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515‐1523. doi:10.1111/epi.13121
30.
KellinghausCRossettiAOTrinkaE, et al. SENSE Registry for status epilepticus. Epilepsia. 2018;59(Suppl 2):150‐154. doi:10.1111/epi.14495
31.
SilvermanECSporerKALemieuxJM, et al.Prehospital care for the adult and pediatric seizure patient: current evidence-based recommendations. West J Emerg Med. 2017;18(3):419‐436. doi:10.5811/westjem.2016.12.32066
32.
HautSRShinnarSMoshéSL. Seizure clustering: risks and outcomes. Epilepsia. 2005;46(1):146‐149. doi:10.1111/j.0013-9580.2005.29004.x
33.
HautSRSwickCFreemanKSpencerS. Seizure clustering during epilepsy monitoring. Epilepsia. 2002;43(7):711‐715. doi:10.1046/j.1528-1157.2002.26401.x
34.
FisherRSBartfeldECramerJA. Use of an online epilepsy diary to characterize repetitive seizures. Epilepsy Behav. 2015;47:66‐71. doi:10.1016/j.yebeh.2015.04.022
35.
ChenBChoiHHirschLJ, et al.Prevalence and risk factors of seizure clusters in adult patients with epilepsy. Epilepsy Res. 2017;133:98‐102. doi:10.1016/j.eplepsyres.2017.04.016
36.
MartinezCSullivanTHauserWA. Prevalence of acute repetitive seizures (ARS) in the United Kingdom. Epilepsy Res. 2009;87(2):137‐143. doi:10.1016/j.eplepsyres.2009.08.006
37.
SinhaSSatishchandraPKalbandBRThennarasuK. New-onset status epilepticus and cluster seizures in the elderly. J Clin Neurosci. 2013;20(3):423‐428. doi:10.1016/j.jocn.2012.02.050
38.
HautSRLiptonRBLeValleyAJHallCBShinnarS. Identifying seizure clusters in patients with epilepsy. Neurology. 2005;65(8):1313‐1315. doi:10.1212/01.wnl.0000180685.84547.7f
39.
HautSR. Seizure clusters: characteristics and treatment. Curr Opin Neurol. 2015;28(2).
40.
SillanpaaMSchmidtD. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. 2008;131(4):938‐944. doi:10.1093/brain/awn037
HarrisPATaylorRThielkeRPayneJGonzalezNCondeJG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381. doi:10.1016/j.jbi.2008.08.010
43.
ChamberlainJMKapurJShinnarS, et al.Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217‐1224. doi:10.1016/s0140-6736(20)30611-5
44.
FisherRSCrossJHFrenchJA, et al.Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522‐530. doi:10.1111/epi.13670
45.
DetynieckiKVan EssPJSequeiraDJWhelessJWMengTCPullmanWE. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double-blind, placebo-controlled trial. Epilepsia. 2019;60(9):1797‐1808. doi:10.1111/epi.15159
46.
CereghinoJJ. Rectal diazepam gel for treatment of acute repetitive seizures in adults. Arch Neurol. 2002;59(12):1915. doi:10.1001/archneur.59.12.1915
47.
DreifussFERosmanNPCloydJC, et al.A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med. 1998;338(26):1869‐1875. doi:10.1056/nejm199806253382602
48.
SzklenerSGodekMKorchutA, et al.Outcome prediction in patients with acute repetitive seizures: application of the Status Epilepticus Severity Score. Epilepsia. 2018;59(5):e68‐e72. doi:10.1111/epi.14061
49.
BesliGEYuksel KaratoprakEYilmazS. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Epilepsy Behav. 2020;111:107289. doi:10.1016/j.yebeh.2020.107289
50.
TrinkaEKalviainenR. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65‐73. doi:10.1016/j.seizure.2016.11.001
51.
KajiAHSchrigerDGreenS. Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. Ann Emerg Med. 2014;64(3):292‐298. doi:10.1016/j.annemergmed.2014.03.025
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
